FDA and EMA-approved noninvasive imaging techniques for basal cell carcinoma subtyping: A systematic review
{{output}}
Background: Basal cell carcinoma (BCC), the most common skin cancer, requires accurate subtyping for optimal treatment. While histopathology is the gold standard, noninvasive imaging offers a biopsy-free alternative, though its a... ...
